Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_assertion type Assertion NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_head.
- NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_assertion description "[Measures of expression of the M2 cell markers CD14, CD68, CD163, and CD204, which are elevated in high-grade gliomas, and the neutrophil/myeloid-derived suppressor cell (MDSC) subset marker CD15, which is reduced, provide the best index of glioma grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_provenance.
- NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_assertion evidence source_evidence_literature NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_provenance.
- NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_assertion SIO_000772 23741072 NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_provenance.
- NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_assertion wasDerivedFrom befree-2016 NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_provenance.
- NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_assertion wasGeneratedBy ECO_0000203 NP1083710.RABbTCUtleexM5wqBOGOJiZgTF6-f6t20BhLwE-X2kims130_provenance.